Trending Now
Gilead Sciences Amplifies Collaboration with Arcus Biosciences in Cancer Drug Development...
In a significant move to advance its position in the oncology sector, Gilead Sciences announced a substantial increase in its stake in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Mustang Bio Inc. (NASDAQ:MBIO) Reports Preliminary Phase 1/2 MB-106 Clinical Study...
Mustang Bio Inc. (NASDAQ:MBIO) has announced preliminary results of its ongoing phase 1/2 MB-106 clinical trial. MB-106 is a CD20-targeted autologous CAR...
MAKE IT MODERN
LATEST REVIEWS
ADC Therapeutics (NYSE:ADCT) Files Biologics License Application With the FDA For...
ADC Therapeutics SA (NYSE:ADCT) has submitted a Biologics Licence Application (BLA) to the FDA for loncastuximab tesirine for treating patients with refractory or relapsed...
MAKE IT MODERN
PERFORMANCE TRAINING
Crypto Stocks Shine as Risk Capital Returns (RIOT, AXXA, CAN)
Investors have been on a wild ride in recent days, with risk assets soaring, then diving, then soaring again. In Tuesday’s buying...
Aikido Pharma Inc (NASDAQ:AIKI) Provides an Update on Its Effort to Identify Compounds to...
The coronavirus's origin, which has affected over seven million people across the world, remains a mystery. This is even though new cases are mounting...
Will Sarepta Therapeutics ($SRPT) shares hit 200$ by the end of the year ?
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) shares closed at $160.72, up by $37.22 (30.14%) at 4:00 PM EDT. In after-hours trading, the stock...
Alector Inc (NASDAQ: ALEC) Announced the Results of the Phase-2 INFRONT-2 Open-Label Study of...
Aelector Inc (NASDAQ: ALEC) is a clinical biotech corporation that recently announced promising results from its Phase-2 INFRONT-2 trial of ALOO1. The Alzheimer's Association International...
CorMedix Inc (NYSEAMERICAN:CRMD) Pleased About FDA’s Priority Review Of Its NDA
The U.S. Food and Drug Administration (FDA) has finally accepted the first NDA belonging to CorMedix Inc (NYSEAMERICAN:CRMD). This company knows the frustration that...
MAKE IT MODERN
